Spero Therapeutics (SPRO) Non-Current Debt (2019 - 2026)
Spero Therapeutics (SPRO) recorded Non-Current Debt of $91,000 in Q2 2026, unchanged from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Non-Current Debt (2019 - 2026) Analysis & Trends
Starting with Q1 2019, Spero Therapeutics' Non-Current Debt history includes 26 quarters.
- Annual Non-Current Debt has a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Debt came in at $87,000 in FY2023 (-9.4%), $96,000 in FY2022 (-30.4%) and $138,000 in FY2021 (-22.0%).
- Quarterly Non-Current Debt has ranged from $13,000 in Q3 2024 to $148,000 in Q3 2021 over the past five years.
- The year-over-year decline in Non-Current Debt has ranged between 9.4% (Q4 2023) and 79.0% (Q3 2024) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Spero Therapeutics | 68.34 Mn | -127.44 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 85,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 107,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 158,000.00 |
| Mar 31, 2021 | 168,000.00 |
| Dec 31, 2020 | 177,000.00 |
| Sep 30, 2020 | 186,000.00 |
API Access
Spero Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();